**Core Concept**
The question assesses the understanding of drug-induced type II hypersensitivity reactions, specifically the mechanism by which certain medications can trigger this immune response. Type II hypersensitivity reactions involve the binding of antibodies to specific antigens on the surface of cells or tissues, leading to their destruction.

**Why the Correct Answer is Right**
In the context of the question, the correct answer involves the process of drug-induced platelet destruction. Sedormid, a sedative, can cause thrombocytopenia by inducing a type II hypersensitivity reaction. This occurs when the drug binds to the surface of platelets, marking them for destruction by the immune system. The antibodies produced against the drug-platelet complex lead to the activation of complement and the phagocytosis of platelets, resulting in thrombocytopenia.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the mechanism of type II hypersensitivity reactions. The correct answer involves the binding of antibodies to the drug-platelet complex, not the production of antibodies against a specific antigen.
* **Option B:** This option is not directly related to the type II hypersensitivity reaction. The correct answer involves the binding of antibodies to the drug-platelet complex, not the activation of a specific enzyme or pathway.
* **Option C:** This option is incorrect because it describes a type I hypersensitivity reaction, which involves the release of histamine and other mediators from mast cells, not the binding of antibodies to a specific antigen on the surface of cells or tissues.

**Clinical Pearl / High-Yield Fact**
It is essential for clinicians to recognize the potential for drug-induced type II hypersensitivity reactions, particularly in patients taking medications like sedormid. This reaction can occur even at therapeutic doses and can have significant clinical consequences, including thrombocytopenia and other bleeding disorders.

**Correct Answer:** C.